John Boozman · LLY
John Boozman's LLY trades
- Transactions
- 4
- Buys / sells
- 2 / 2
- Disclosed range
- $4K – $60K
- Last filed
- 2026-08-24
LLY transactions reported by John Boozman
| Type | Owner | ||||
|---|---|---|---|---|---|
Eli Lilly and Company LLY | Sale | Joint | $1,001 - $15,000 | 2026-08-24 #51455bcd-4966-4e77-b481-09897ada81ae | |
Eli Lilly and Company LLY | Sale | Joint | $1,001 - $15,000 | 2025-12-08 #3a779539-8451-49d2-8419-d3eb72c7922a | |
Eli Lilly and Company LLY | Purchase | Joint | $1,001 - $15,000 | 2025-09-12 #59bccfcc-9400-4d3d-917f-ce22a0fd2feb | |
Eli Lilly and Company LLY | Purchase | Joint | $1,001 - $15,000 | 2025-09-12 #59bccfcc-9400-4d3d-917f-ce22a0fd2feb |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
Members-only research
What members are reading this month
Sep 22, 2026
Meta jumped 11%. What must happen next to justify the price?A member research report on Meta’s AI rally: Muse, subscription economics, the cash-flow burden, legal costs and the earnings assumptions behind the new price.
Feb 23, 2026
Newmont and the gap between a gold rally and shareholder cashA February 23, 2026 historical cutoff tests whether portfolio simplification and cost control could turn stronger gold economics into cash.
The thesis, the numbers behind it, and what would break it. Full access is $15 a month.
Read the full researchOther members of Congress who reported LLY
More tickers reported by John Boozman
John Boozman and LLY — questions
Did John Boozman buy or sell LLY?
Senate eFD filings for 2025 and 2026 show 2 purchases and 2 sales of Eli Lilly and Company (LLY) reported by John Boozman, between 2025-08-11 and 2025-11-21. Reported owner: Joint.
How much LLY did John Boozman trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K – $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last LLY filing by John Boozman?
The most recent periodic transaction report containing a LLY row was filed on 2026-08-24. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Eli Lilly and Company. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
John Boozman LLY disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
Members-only research
$15/mo or $150/yr · cancel future renewals anytime · sources included